ask="3.4600"
ask_size="2500"
average_daily_volume="3456"
bid="3.0000"
bid_size="1000"
book_value="0.9450"
change="-0.6955"
change_from_200_day_moving_average="-0.1302"
change_from_50_day_moving_average="-0.0437"
change_from_52_week_high="-2.2455"
change_From_52_week_low="0.4945"
change_in_percent="-18.7973%"
close="3.0045"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4290"
ebitda="-13.17M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.0700"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="23083000"
high="3.6400"
high_52_weeks="5.2500"
last_trade_date="1/18/2017"
last_trade_price="3.0045"
last_trade_size="200"
last_trade_time="3:55pm"
low="3.0000"
low_52_weeks="2.5100"
market_capitalization="107.37M"
moving_average_200_day="3.1347"
moving_average_50_day="3.0482"
name="Oasmia Pharmaceutical AB - Amer"
notes="N/A"
one_year_target_price="6.0000"
open="3.6400"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-4.1550%"
percent_change_from_50_day_moving_average="-1.4349%"
percent_change_from_52_week_high="-42.7714%"
percent_change_from_52_week_low="+19.7012%"
previous_close="3.7000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.9153"
price_per_sales="73.3442"
revenue="1.80M"
shares_outstanding="35736000"
short_ratio="2.9400"
stock_exchange="NCM"
symbol="OASM"
volume="25820"
weeks_range_52="2.5100 - 5.2500"
